Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Vista Pharmaceuticals has informed that the members of the Company have approved all the resolutions bearing item no. 1 & 2 contained in the Notice of 29th Annual General Meeting of the Company with requisite majority. The Company had appointed NVSS Suryanarayana Rao, Company Secretary in practice as the Scrutinizer for remote e-voting and venue e-voting at the AGM. The Scrutinizer has submitted his report on 27th September, 2021. In this connection, the company has enclosed the consolidated results of the remote e-voting and venue e-voting at the Video Conferencing (VC) / Other Audio-Visual Means (OAVM) meeting in the format prescribed together with the Scrutinizer’s Report. On the basis of the report received from the Scrutinizer, the Company has declared that the Resolutions set out in the notice of 29th AGM were passed with requisite majority in favour of the Resolutions.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1751.05 |
Dr. Reddys Lab | 1163.70 |
Cipla | 1515.45 |
Lupin | 1936.75 |
Zydus Lifesciences | 831.40 |
View more.. |